CSL Limited (ASX:CSL) (OTCMKTS:CSLLY) is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 30,000 people.
Csl Limited
ASX:CSL ISIN:AU000000CSL8
新闻
###
197,391 公司背景浏览
- 本页浏览人次: (过去7日: 128) (过去30日: 508) (自发布以来: 42255)